Photo of Krish Patel

Krish Patel, M.D.


Hematology, Medical Oncology

Accepting New Patients


Professional Statement

Dr. Patel is a 2018 Seattle Met Top Doctor Award winner. He is passionate about caring for patients with all forms of blood cancers and has a particular interest in lymphomas. Dr. Patel recognizes each patient's illness experience is unique and is focused on providing care that is both evidence-based and personalized to the individual patient. He values the importance of communication in the physician-patient experience and emphasizes shared decision making to help patients navigate their illness. He is excited to help develop novel therapies for blood cancer patients through clinical trials at Swedish. Dr. Patel enjoys traveling, cooking, and being outdoors with his wife. He is a keen sports fan and enjoys photographing the scenic PNW.

Read More


Duke University School of Medicine
medical school, 2009
Duke University School of Medicine
residency, Internal Medicine, 2012
Duke University School of Medicine
fellowship, Hematology/Med Oncology, 2016

Board Certifications

American Board of Internal Medicine
American Board of Internal Medicine
Internal Medicine
American Board of Internal Medicine
Medical Oncology

Clinical Interests

  • Blood Cancer
  • Cancer Chemotherapy
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Stem Cell Transplant
Read More


  • Patel K, Abernethy A, Todd HK, Thomas Jr CR. Rapid Learning Systems. Oncologic Emergency Medicine: Principles and Practice. Springer International Publishing. p79-93. May 2016.
  • Patel K, Kim HS, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010; 17 (1): 41-52. PMID: 20129246.
  • Nguyen P, Cui H, Bisht KS, Sun L, Patel K, Lee RS, Kugoh H, Oshimura M, Feinberg AP, Gius D. CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region. Cancer Res. 2008; 68 (14): 5546-51. PMID: 18632606.
  • Patel K. "SIRT3 at the Junction of Superoxide Regulation." Platform Presentation. American Society for Therapeutic Radiology and Oncology (ASTRO) 50th Annual Meeting, Boston, Mass. Sept 21st-25th, 2008.
  • Patel K. "SIRT3 as a regulator of Intracellular Superoxide Levels." Platform Presentation. Mitochondrial Symposium National Institutes of Health. Bethesda, Md. January 11, 2008.

Professional Associations

American Society of Hematology, American Society of Clinical Oncology, Alpha Omega Alpha
Read More


  • English

Practice Locations

Krish Patel practices at one location

Affiliated Facilities
  • Swedish Edmonds